Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 2:56 PM

Peramivir

Type: Keyphrase
Name: Peramivir
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Conflicts & Crime)
Centers for Disease Control and Prevention - Click to view image in its original context
Centers for Disease Control and Prevention
Centers for Disease Control overturn ruling on flu victim
::: Home Search Search News 11/19/2009 (Taipei Times)The Centers for Disease Control (CDC) on Wednesday overturned its decision regarding urgent medical treatment for a 10-year-old boy suffering from A(H1N1) influenza whose medical condition makes the ... [MyEGov Taiwan - 11/19/2009]
First Reported 12 hours ago - Updated 12 hours ago - 1 Documents
BioCryst $49M Public Offering Cashes in on Stock Momentum
By Trista Morrison Staff WriterBioCryst Pharmaceuticals Inc. priced a $49 million public offering, cashing in on the 593 percent gain its shares have posted so far this year thanks to progress with flu drug peramivir.After starting at $1.50 in January, ... [BioWorld - 12 hours ago]
First Reported 11/16/2009 - Updated 11/16/2009 - 3 Documents (in Health)
Woman dies of swine flu as virus' death toll in Israel reaches 48
A 51-year-old Nazareth woman who suffered from high blood pressure died on Monday from complications of swine flu, becoming the 48th person to die of the pandemic in Israel. Her high blood pressure could not be counted as a serious medical condition, ... [Haaretz - 11/16/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents
BioCryst Pharma to Sell up to 5.75M New Shares
Flu drug developer BioCryst Pharmaceuticals Inc. said Tuesday it plans to sell as many as 5.75 million new shares of stock.BioCryst said it will offer 5 million shares to the public. The banks underwriting its offer will have the option to buy another ... [ABC News - 11/17/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents (in Biology)
BioCryst hopes to raise $57.8M in stock offering to fund R&D efforts
BioCryst Pharmaceuticals plans to sell 5 million shares of stock in order to secure $57.8 million. The biotech company will use the money from the stock offering to fund clinical studies of lymphoma treatment Forodesine and BCX-4208, a gout drug, as well ... [SmartBrief - 11/18/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents (in Health)
BioCryst sees healthy future after flu drug
Jon Stonehouse is seeking life beyond Peramivir.Recent revenue announcements topping $100 million have given s CEO a financial cushion required to identify the next drugs to put in the firms development pipeline. Peramivir is BioCrysts lead experimental ... [Biz Journals - 11/16/2009]
Entities: Peramivir, Swine Flu
First Reported 11/05/2009 - Updated 11/06/2009 - 6 Documents (in Health)
HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs
The U.S. Department of Health and Human Services (HHS) today announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.Patients hospitalized with 2009 H1N1 ... [News-Medical.Net - 11/06/2009]
First Reported 10/26/2009 - Updated 10/27/2009 - 5 Documents
Peramivir Authorized to Treat H1N1 Influenza
The FDA has issued an emergency use authorization (EUA) for BioCryst Pharmaceuticals’ antiviral peramivir intravenous drug for certain adult andpediatric patients with confirmed or suspected influenza A (H1N1). ... [FDA News - 10/27/2009]
First Reported 10/25/2009 - Updated 10/25/2009 - 4 Documents
FDA Gives Green Light to Peramivir
The FDA is allowing the use of peramivir, an experimental antiviral drug, to treat severe cases of H1N1 or swine flu. ... [WSJ.com: What's News US - 10/25/2009]
First Reported 10/24/2009 - Updated 10/24/2009 - 5 Documents (in Health)
FDA OKs Emergency Use of IV Flu Drug
The investigational antiviral peramivir can be used against the H1N1 pandemic flu in certain critically ill patients, the FDA has announced.Acting on a request from the CDC, the agency issued an emergency use authorization for the drug, which is the only ... [MedPage Today - 10/24/2009]
First Reported 11/04/2009 - Updated 11/05/2009 - 3 Documents
BioCryst Receives First Peramivir Order From U.S. Government
BIRMINGHAM, Ala., Nov. 5 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced it has received an initial order for 10,000 courses of intravenous (i.v.) peramivir (600 mg once-daily for five days) with a value of $22.5 ... [Street Insider - 11/05/2009]
First Reported 10/29/2009 - Updated 10/29/2009 - 2 Documents (in Health)
FDA Approves Use of Experimental Antiviral to Treat 2009 H1N1
In response to President Obama declaring the 2009 H1N1 a public health emergency, the Food and Drug Administration has approved the emergency use of Peramivir IV to treat certain patients with suspected or laboratory confirmed H1N1 infection or infection ... [Michigan Pharmacists Association - 10/29/2009]

Quotes

...option for physicians in the US during the ongoing influenza health emergency,' said Jon P Stonehouse, chief executive officer at BioCryst. "BioCryst has worked with HHS to enable the Government to rapidly deploy an initial supply of peramivir, and we are prepared to deliver more." To prepare for peramivir orders that BioCryst may receive from the US or other governments during this pandemic emergency, BioCryst is completing production...
US FDA issues emergency use authorization for BioCryst's Peramivir [PharmaBiz - 10/27/2009]
...'Peramivir and zanamivir are really two separate issues; it's not that one would be approved [for an EUA] and not the other,' he commented. "With the body of evidence available at this time, the FDA felt there was enough information available on safety and efficacy to approve peramivir. Zanamivir could be approved in the future." So far, between 6% and 25% of hospitalized H1N1 patients have required intensive care unit placement, Peters reported...
Emergency authorization for peramivir draws fast response [Centre For Infectious Disease Research and Policy - 10/27/2009]
...'It's highly potent on the H1N1 virus,' said Jon Stonehouse, the President and CEO of Biocryst. "There are lab tests conducted by the CDC that show it's the most potent inhibitor of the H1N1 virus." But the drug hasn't gone through all the necessary and time-consuming FDA trials yet...
Families Line up for Shots as H1N1 Spreads [CBS News - 10/25/2009]
...'This will be a life and death decision,' Lieberman said. Sebelius' reply: "Yes, senator, all of that is correct and it is - it is imminent." CBS News reported on the case of 51-year-old John Boudrot...
Feds Inch Closer to Allowing Key H1N1 Drug [CBS News - 10/22/2009]

More Content

All (85) | News (82) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (1)
sort by: Date | Relevance
BioCryst $49M Public Offering Cashes in on Stoc... [BioWorld - 12 hours ago]
Centers for Disease Control overturn ruling on ... [MyEGov Taiwan - 11/19/2009]
Experimental swine flu drug used on boy [China Post - 11/19/2009]
BioCryst hopes to raise $57.8M in stock offerin... [SmartBrief - 11/18/2009]
BioCryst Pharma to Sell up to 5.75M New Shares [ABC News - 11/17/2009]
BioCryst drama accelerates [Stockhouse Canada - 11/16/2009]
Woman dies of swine flu as virus' death toll in... [Haaretz - 11/16/2009]
Women dies of swine flu, becoming 48th fatality... [Haaretz - 11/16/2009]
BioCryst sees healthy future after flu drug [Biz Journals - 11/16/2009]
Short Blood Supply Means Long Outlook for Cerus [Seeking Alpha - 11/15/2009]
Update: Influenza Activity --- United States, A... [Food Consumer - 11/14/2009]
Shorting The Blood Supply - Go Long Cerus (CERS) [InvestorPlace.com - 11/13/2009]
4,000 Have Died From H1N1, Says CDC; Japanese A... [Research & Development - 11/12/2009]
Emergency use of peramivir approved [Pharmacist.com - 11/12/2009]
Peramivir for Treatment of 2009 H1N1 Influenza [AIDS Clinical Care - 11/09/2009]
Only Pregnant Animals Tested With Peramivir For... [Individual.com - 11/07/2009]
HHS orders IV antiviral drugs [Centre For Infectious Disease Research and Policy - 11/06/2009]
Nov 5 HHS statement [Centre For Infectious Disease Research and Policy - 11/06/2009]
HHS announces contract awards for up to 120,000... [News-Medical.Net - 11/06/2009]
BioCryst (BCRX) Receives Order for 10K Courses ... [Street Insider - 11/06/2009]
HHS Orders Intravenous Antiviral Flu Medication... [Earthtimes.org - 11/05/2009]
HHS Orders Intravenous Antiviral Flu Medication... [RBC Dain Rauscher - 11/05/2009]
BioCryst ships 10K doses of flu drug to government [Biz Journals - 11/05/2009]
BioCryst Receives $22.5 Million Peramivir Order [ABC News - 11/05/2009]
BEFORE THE BELL-BioCryst shares rise, gets Pera... [Forbes.com - 11/05/2009]
BioCryst Receives First Peramivir Order From U.... [Street Insider - 11/05/2009]
UPDATE 1-Daiichi Sankyo begins late-stage trial... [FinanzNachrichten.de - 11/05/2009]
BioCryst (BCRX) Partner In Japan Files NDA for ... [Street Insider - 11/05/2009]
Treating H1N1: FDA authorizes use of unapproved... [NECN.com - 11/05/2009]
BioCrysts Partner Shionogi Files for Peramivir ... [Street Insider - 11/04/2009]
1 2 3
In Focus
  •  
Wyatt Andrews, Kathleen Sebelius, Martin Hirsch, [more]
  •  
Biocryst Pharmaceuticals Inc, Shionogi & Co., Ltd., GlaxoSmithKline plc, [more]
  •  
Food and Drug Administration, Centers for Disease Control and Preve ..., United States Department of Health an ..., [more]
  •  
Influenza A H1N1 Virus, emergency, Antiviral, [more]
  •  
Birmingham, Haifa (Israel), Atlanta, [more]
  •  
United States, Israel, Japan, [more]
  •  
Medicine, Diseases, Biology, [more]
  •  
Pharma & Biotech, Health, Agriculture, [more]
CBS News, Street Insider, H5N1, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Israel: 48 deaths [H5N1 - 11/16/2009]
Via Haaretz: Woman dies of swine flu as virus' death toll in Israel reaches 48. Excerpt:A 51-year-old Nazareth woman who suffered from high blood pressure died on ...
Will Peramivir help? [H5N1 - 10/20/2009]
Thanks to the reader who sent the link to this CBS News report: Life-Saving H1N1 Drug Unavailable to Most. Excerpt:Last month, 51-year-old John Boudrot was so sick ...
1

  •  
  •  
  •